UCB, a global biopharmaceutical company, today announced the opening of applications for the second annual UCB U.S. Myasthenia Gravis Scholarship™, supporting individuals impacted by myasthenia gravis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback